So Wong

2PUBLICATIONS
36CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 23, 2024
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma.

James Brugarolas, Gregory Obara, Kathryn E Beckermann

|Oct 03, 2022
HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans.

Yuanqing Ma, Allison Joyce, Olivia Brandenburg

Pageof 1